Dr. Otmar Wolf Albrand, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 1202 Waterloo Lake Dr, Denison, TX 75020 Phone: 903-465-8135 Fax: 903-465-4859 |
Gary M Bloomgarden, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 5012 S Us Highway 75 Ste 240, Denison, TX 75020 Phone: 903-416-6460 Fax: 903-416-6461 |
News Archive
A nicotinic drug approved for smoking cessation significantly improved the walking ability of patients suffering from an inherited form of ataxia, reports a new clinical study led by University of South Florida researchers.
FUJIFILM Medical Systems U.S.A., Inc., a leading provider of diagnostic imaging products and medical informatics solutions, will showcase its evolving Enterprise Imaging portfolio of Synapse integrated solutions and spotlight enhanced features and next generation upgrades at the Radiological Society of North America 2016 conference and exhibition held November 27 - December 2, 2016 at McCormick Center in Chicago, Illinois.
Adocia, a biotechnology company specializing in the development of ‘best-in-class' medicines from already approved therapeutic proteins, announced today that it had agreed with Eli Lilly and Company not to continue further joint research under the licensing agreement signed in December 2011 relating to use of Adocia's BioChaperone(R) technology for the formulation of fast acting insulin analog formulated with the BioChaperone(R) technology. Consequently, the two companies have terminated the collaboration.
Medivation, Inc. and Astellas Pharma Inc. today announced that patient enrollment was completed on November 15, 2010 in the Phase 3 AFFIRM study of the investigational drug MDV3100, a novel, triple-acting oral androgen receptor antagonist, in patients with advanced prostate cancer who have previously been treated with chemotherapy. The companies also announced that clinical development of MDV3100 in Japan has commenced, with the initiation of patient dosing in a Phase 1-2 clinical study.
New research finds COVID-19 vaccination during pregnancy results in significantly greater antibody persistence in the infants compared to natural infection of the mothers during pregnancy.
› Verified 3 days ago